Inventia is an Australian owned company established in Sydney in 2013. Their key focus is on the development, manufacture and sale of equipment and reagents for advanced medical research assays by means of 3D bioprinting. RASTRUM, is a bench-top medical device that prints 3D cell models, using living human cells, quickly and efficiently within a safe, self-contained environment. Inventia has used a combination of IP rights to protect their business in their commercialisation journey.
Hear about Inventia and their journey to commercialisation and IP protection.
Find out more about: